Search research articles
Contact Us
Filters
Showing results (141-150 of 154) with videos related to
Page
of 16
Sort By:
Nature Medicine
|
October 9, 2023
ctDNA response after pembrolizumab in non-small cell lung cancer: phase 2 adaptive trial results
Valsamo Anagnostou, Cheryl Ho, Garth Nicholas, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
August 16, 2023
Mepitel film for the prevention and treatment of acute radiation dermatitis in breast cancer: a systematic review and meta-analysis of randomized controlled trials
Saba Shariati, Tara Behroozian, Samantha Kennedy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 18, 2009
Randomized, double-blind trial of carboplatin and paclitaxel with either daily oral cediranib or placebo in advanced non-small-cell lung cancer: NCIC clinical trials group BR24 study
Glenwood D Goss, Andrew Arnold, Frances A Shepherd, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
November 6, 2017
Gender and age make no difference in the re-irradiation of painful bone metastases: A secondary analysis of the NCIC CTG SC.20 randomized trial
Ronald Chow, Keyue Ding, Vithusha Ganesh, et al.
The New England Journal of Medicine
|
August 31, 2012
Intermittent androgen suppression for rising PSA level after radiotherapy
Juanita M Crook, Christopher J O'Callaghan, Graeme Duncan, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
November 20, 2021
CCTG BR34: A Randomized Phase 2 Trial of Durvalumab and Tremelimumab With or Without Platinum-Based Chemotherapy in Patients With Metastatic NSCLC
Natasha B Leighl, Scott A Laurie, Glenwood D Goss, et al.
JAMA Oncology
|
September 17, 2020
Efficacy and Safety of nab-Paclitaxel vs Paclitaxel on Survival in Patients With Platinum-Refractory Metastatic Urothelial Cancer: The Canadian Cancer Trials Group BL.12 Randomized Clinical Trial
Srikala S Sridhar, Normand Blais, Ben Tran, et al.
Human Genetics
|
September 13, 2013
A genome- and phenome-wide association study to identify genetic variants influencing platelet count and volume and their pleiotropic effects
Khader Shameer, Joshua C Denny, Keyue Ding, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 9, 2022
Mepitel Film for the Prevention of Acute Radiation Dermatitis in Breast Cancer: A Randomized Multicenter Open-Label Phase III Trial
Tara Behroozian, Lauren Milton, Irene Karam, et al.
The Lancet. Oncology
|
December 3, 2014
Dacomitinib compared with placebo in pretreated patients with advanced or metastatic non-small-cell lung cancer (NCIC CTG BR.26): a double-blind, randomised, phase 3 trial
Peter M Ellis, Frances A Shepherd, Michael Millward, et al.
Page
of 16
Search research articles
Search
Showing results (141-150 of 154) with videos related to
Sort By:
Page
of 16
Nature Medicine
|
October 9, 2023
ctDNA response after pembrolizumab in non-small cell lung cancer: phase 2 adaptive trial results
Valsamo Anagnostou, Cheryl Ho, Garth Nicholas, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
August 16, 2023
Mepitel film for the prevention and treatment of acute radiation dermatitis in breast cancer: a systematic review and meta-analysis of randomized controlled trials
Saba Shariati, Tara Behroozian, Samantha Kennedy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 18, 2009
Randomized, double-blind trial of carboplatin and paclitaxel with either daily oral cediranib or placebo in advanced non-small-cell lung cancer: NCIC clinical trials group BR24 study
Glenwood D Goss, Andrew Arnold, Frances A Shepherd, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
November 6, 2017
Gender and age make no difference in the re-irradiation of painful bone metastases: A secondary analysis of the NCIC CTG SC.20 randomized trial
Ronald Chow, Keyue Ding, Vithusha Ganesh, et al.
The New England Journal of Medicine
|
August 31, 2012
Intermittent androgen suppression for rising PSA level after radiotherapy
Juanita M Crook, Christopher J O'Callaghan, Graeme Duncan, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
November 20, 2021
CCTG BR34: A Randomized Phase 2 Trial of Durvalumab and Tremelimumab With or Without Platinum-Based Chemotherapy in Patients With Metastatic NSCLC
Natasha B Leighl, Scott A Laurie, Glenwood D Goss, et al.
JAMA Oncology
|
September 17, 2020
Efficacy and Safety of nab-Paclitaxel vs Paclitaxel on Survival in Patients With Platinum-Refractory Metastatic Urothelial Cancer: The Canadian Cancer Trials Group BL.12 Randomized Clinical Trial
Srikala S Sridhar, Normand Blais, Ben Tran, et al.
Human Genetics
|
September 13, 2013
A genome- and phenome-wide association study to identify genetic variants influencing platelet count and volume and their pleiotropic effects
Khader Shameer, Joshua C Denny, Keyue Ding, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 9, 2022
Mepitel Film for the Prevention of Acute Radiation Dermatitis in Breast Cancer: A Randomized Multicenter Open-Label Phase III Trial
Tara Behroozian, Lauren Milton, Irene Karam, et al.
The Lancet. Oncology
|
December 3, 2014
Dacomitinib compared with placebo in pretreated patients with advanced or metastatic non-small-cell lung cancer (NCIC CTG BR.26): a double-blind, randomised, phase 3 trial
Peter M Ellis, Frances A Shepherd, Michael Millward, et al.
Page
of 16